French drug major Sanofi and the US unit of Israel’s Teva Pharmaceutical Industries have presented new, detailed results from the RELIEVE UCCD Phase IIb study of duvakitug, a human IgG1-λ2 monoclonal ...

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s diseaseNew detailed data from the RELIEVE UCCD ...

Publicis Groupe has acquired an influencer agency based in Brazil, expanding its presence in the Latin American market. The move aims to leverage the agency’s extensive network of over 500,000 ...

This can be found among the Granolas, a group of 11 European multinationals, selected by US bank Goldman Sachs, which is made ...

The American Pharmacists Association (APhA) has selected seven recipients of its 2025 Immunization Champion Awards, ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

The U.S. is in a severe flu season, and antiviral medications such as Tamiflu can help if you get sick—but it's not recommended for everyone. Here's what you need to know about the medication.

Stock exchange NSE has announced a number of changes in key indices, such as the Nifty 50, the Nifty Next 50, and the Nifty ...

The US Food and Drug Administration (FDA) said it has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is now resolved.